CFF Clinical Research Award

The CFF Clinical Research Award sits under the Cystic Fibrosis Foundation's academic funding portfolio and supports investigator-initiated clinical, translational, and epidemiological research in cystic fibrosis. It is the foundation's main larger-scale clinical mechanism outside the Path to a Cure gene repair and replacement track. The award runs from $150,000 to $350,000 per year for three years, with indirect costs capped at 12 percent. It is available to US universities and research organizations, requires prior pilot evidence, and uses two annual cycles: one in the fall with a letter of intent before full submission, and one in the spring with the same staged process. Review goes through the Clinical Research Committee. The program is strongest for studies with clear patient relevance, workable recruitment, and enough supporting data to justify a three-year commitment. Applicants do best when the protocol, endpoints, and study operations are already well developed, because the foundation is backing a defined clinical research plan rather than an open-ended idea.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.